Literature DB >> 19609716

Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients.

Nanthawan Mekha1, Takashi Sugita, Reiko Ikeda, Akemi Nishikawa, Rinrapas Autthateinchai, Natteewan Poonwan, Pathom Sawanpanyalert.   

Abstract

Trichosporonosis due to Trichosporon asahii is a life-threatening infection with a very poor prognosis. We analyzed the genotype of intergenic transcribed spacer (IGS) region 1 of the rRNA gene and determined the drug susceptibility of 101 T. asahii isolates obtained from Thai patients to collect basic information on trichosporonosis in Thailand. Of the five genotypes in the IGS region identified in this study, types 1 and 3 were predominant in Thailand. The distribution in Thailand differs from that in other countries, suggesting that there is a geographic substructure among T. asahii clinical isolates. Voriconazole appeared to be the most active drug.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 19609716     DOI： 10.1007/s11046-009-9225-5

Source DB:  PubMed          Journal:  Mycopathologia        ISSN： 0301-486X            Impact factor:   2.574


  13 in total

1.  Sequence analysis of the ribosomal DNA intergenic spacer 1 regions of Trichosporon species.

Authors:  Takashi Sugita; Masamitsu Nakajima; Reiko Ikeda; Toshiharu Matsushima; Takako Shinoda
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

Review 2.  Infections due to emerging and uncommon medically important fungal pathogens.

Authors:  T J Walsh; A Groll; J Hiemenz; R Fleming; E Roilides; E Anaissie
Journal:  Clin Microbiol Infect       Date:  2004-03       Impact factor: 8.067

3.  Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole.

Authors:  Rama Falk; Dana G Wolf; Mervyn Shapiro; Itzhack Polacheck
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

4.  Molecular identification, genotyping, and drug susceptibility of the basidiomycetous yeast pathogen Trichosporon isolated from Turkish patients.

Authors:  Ayse Kalkanci; Takashi Sugita; Sevtap Arikan; Mine Yucesoy; Beyza Ener; Feza Otag; Nuri Kiraz; Semra Kustimur; Banu Sancak; Canan Evci; Gurol Emektas
Journal:  Med Mycol       Date:  2010-02       Impact factor: 4.076

5.  Susceptibility patterns and molecular identification of Trichosporon species.

Authors:  Juan L Rodriguez-Tudela; Teresa M Diaz-Guerra; Emilia Mellado; Virginia Cano; Cecilia Tapia; Alexander Perkins; Alicia Gomez-Lopez; Laura Rodero; Manuel Cuenca-Estrella
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

6.  Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units.

Authors:  D G Wolf; R Falk; M Hacham; B Theelen; T Boekhout; G Scorzetti; M Shapiro; C Block; I F Salkin; I Polacheck
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

7.  Analysis of Trichosporon isolates obtained from the houses of patients with summer-type hypersensitivity pneumonitis.

Authors:  Takashi Sugita; Reiko Ikeda; Akemi Nishikawa
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

8.  Detection of a wide range of medically important fungi by the polymerase chain reaction.

Authors:  K Makimura; S Y Murayama; H Yamaguchi
Journal:  J Med Microbiol       Date:  1994-05       Impact factor: 2.472

Review 9.  Summer-type hypersensitivity pneumonitis.

Authors:  M Ando; M Suga; Y Nishiura; M Miyajima
Journal:  Intern Med       Date:  1995-08       Impact factor: 1.271

10.  Fungemia in non-HIV-infected patients: a five-year review.

Authors:  Siriluck Anunnatsiri; Ploenchan Chetchotisakd; Piroon Mootsikapun
Journal:  Int J Infect Dis       Date:  2008-07-23       Impact factor: 3.623
View more
  10 in total

1.  Invasive Infections Due to Trichosporon: Species Distribution, Genotyping, and Antifungal Susceptibilities from a Multicenter Study in China.

Authors:  Li-Na Guo; Shu-Ying Yu; Po-Ren Hsueh; Abdullah M S Al-Hatmi; Jacques F Meis; Ferry Hagen; Meng Xiao; He Wang; Cinzia Barresi; Meng-Lan Zhou; G Sybren de Hoog; Ying-Chun Xu
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

2.  Correlation of Trichosporon asahii Genotypes with Anatomical Sites and Antifungal Susceptibility Profiles: Data Analyses from 284 Isolates Collected in the Last 22 Years across 24 Medical Centers.

Authors:  Elaine Cristina Francisco; João N de Almeida Junior; Flávio Queiroz-Telles; Valério Rodrigues Aquino; Ana Verena A Mendes; Marcio de Oliveira Silva; Paulo de Tarso O E Castro; Thais Guimarães; Vinicius Ponzio; Rosane C Hahn; Guilherme M Chaves; Arnaldo L Colombo
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

3.  Emerging Trichosporon asahii in elderly patients: epidemiological and molecular analysis by the DiversiLab system.

Authors:  M Treviño; C García-Riestra; P Areses; X García; D Navarro; F J Suárez; I A López-Dequidt; O Zaragoza; M Cuenca-Estrella
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-10       Impact factor: 3.267

4.  Three-locus identification, genotyping, and antifungal susceptibilities of medically important Trichosporon species from China.

Authors:  Li-Na Guo; Meng Xiao; Fanrong Kong; Sharon C-A Chen; He Wang; Tania C Sorrell; Wei Jiang; Hong-Tao Dou; Ruo-Yu Li; Ying-Chun Xu
Journal:  J Clin Microbiol       Date:  2011-09-07       Impact factor: 5.948

5.  In vitro interaction of itraconazole with amphotericin B, caspofungin, and terbinafine against clinical isolates of Trichosporon asahii.

Authors:  Houmin Li; Jianjun Qiao; Zhe Wan; Jianzhong Zhang
Journal:  Mycopathologia       Date:  2010-12-14       Impact factor: 2.574

6.  Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients.

Authors:  Zhikuan Xia; Rongya Yang; Wenling Wang; Lin Cong
Journal:  Mycopathologia       Date:  2011-10-07       Impact factor: 2.574

Review 7.  Current knowledge of Trichosporon spp. and Trichosporonosis.

Authors:  Arnaldo L Colombo; Ana Carolina B Padovan; Guilherme M Chaves
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

8.  Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.

Authors:  Gulsen Hazirolan; Emilia Canton; Selma Sahin; Sevtap Arikan-Akdagli
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

9.  Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B.

Authors:  Isabel Antonieta Iturrieta-González; Ana Carolina Barbosa Padovan; Fernando César Bizerra; Rosane Christine Hahn; Arnaldo Lopes Colombo
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

Review 10.  Invasive Trichosporon Infection: a Systematic Review on a Re-emerging Fungal Pathogen.

Authors:  João N de Almeida Júnior; Christophe Hennequin
Journal:  Front Microbiol       Date:  2016-10-17       Impact factor: 5.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.